The association with RA risk was similar after additionally adjusted for prevalent diseases (CVD, cancer, diabetes), lipid-lowing drugs and NSAIDs taken, but was attenuated by nearly 20% in magnitude after further adjusted for traditionally clinical blood measures (albumin, HDL-cholesterol, LDL-cholesterol, triglycerides, C reactive protein). This evidence concerns the gene ALB and rheumatoid arthritis.